Clinical Trials Logo

Situs Inversus clinical trials

View clinical trials related to Situs Inversus.

Filter by:

NCT ID: NCT05524324 Not yet recruiting - Clinical trials for Congenital Heart Disease

Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT

RIGHT-CRT
Start date: September 2022
Phase: N/A
Study type: Interventional

The main objective of RIGHT-CRT is to assess the impact/efficacy of CRT on functional capacity in ACHD patients with SRV.

NCT ID: NCT05160116 Completed - Clinical trials for Transposition of Great Vessels

Influence of Timing of Switch Operation in Transposition of Great Arteries

Start date: December 15, 2021
Phase:
Study type: Observational

Transposition of great vessels are usually corrected by an arterial switch operation. This operation is often done during the first week of life as surgical delays lead to deconditioned left ventricle. On the other hand early surgery carries also risks as neonatal physiology may have problems adapting to an intervention under cardiopulmonary bypass, possible pulmonary hypertension. Arterial switch operation between 2008 and 2020 done at our center will be reviewed. Primary outcome will be mortality or severe postoperative morbidity. Patients will be divided in 2 groups according to the presence or absence of the primary outcome. After propensity score matching, they will be analysed according to the timing of operation.

NCT ID: NCT05137873 Recruiting - Clinical trials for Great Vessels Transposition Surgery

Measurement of the Prevalence of Sensory Integration Disorders in Babies Having Heart Disease Surgery for Transposition of the Great Vessels Before 6 Months of Age

SENSOCOEUR
Start date: April 14, 2022
Phase:
Study type: Observational

The purpose of this study is to mesure the prevalence of severe sensory integration disorders in babies after one week of their heart surgery.

NCT ID: NCT05089773 Completed - Outcome, Fatal Clinical Trials

Outcomes of Transposition of the Great Arteries After Arterial Switch Operation

Start date: December 1, 2019
Phase:
Study type: Observational

Transposition of the great arteries (TGA) is a complex cyanotic congenital heart disease and patients suffer from a high mortality rate within one year of age without appropriate management. The therapeutic effect of arterial switch operation (ASO) is satisfactory with low surgery mortality of 2-5%, and thus, has become the treatment of choice for surgical correction of d-TGA. Outcomes of ASO in TGA in china are rare. This is a retrospective study reporting the outcomes of ASO in TGA.

NCT ID: NCT04788082 Withdrawn - Clinical trials for Transposition of the Great Arteries

Clinical Impact of Rapid Prototyping 3D Models for Surgical Management

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Patient-specific, 3D printed models have been utilized in preoperative planning for many years. Among researchers and clinicians, there is a perception that preoperative exposure to 3D printed models, derived from patient images (CT or MRI), aid in procedural planning. 3D printed models for heart surgery have the potential to improve a clinician's preparedness and therefore may reduce surgically-related morbidity and mortality. This randomized clinical trial aims to evaluate whether pre-procedural planning of surgeons exposed to a patient-specific 3D printed heart model will decrease cardiopulmonary bypass time, morbidity, and mortality.

NCT ID: NCT04616222 Recruiting - Clinical trials for Transposition of Great Vessels

A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels

CELSIOR-TGV
Start date: September 1, 2020
Phase:
Study type: Observational

Celsior® is an organ preservation solution used for the harvesting and the preservation of solid organs. Its use as a crystalloid cardioplegia solution has been established recently. Its main advantage is the long duration of myocardial protection. Compared to the other cardioplegia solutions, it allows a reduced amount of solution administered during the surgery and fewer interruptions during the intervention for the administration of supplemental doses of cardioplegia for long and complex operations. The objective of this register is to compare the safety and the efficacy of Celsior® to the old cardioplegia solution Saint-Thomas used as cardioplegia solution in surgery of the transposition of great vessels, the arterial switch operation.

NCT ID: NCT03771534 Recruiting - Clinical trials for TGA - Transposition of Great Arteries

Acute Maternal Hyperoxygenation for Fetal Transposition of the Great Arteries (TGA)

Start date: September 20, 2018
Phase: N/A
Study type: Interventional

This prospective study will examine whether transient maternal hyperoxygenation is useful as a diagnostic test to more accurately detect TGA patients with poor vs. good neonatal intra-cardiac mixing of blood, based on the in-utero response to oxygen exposure. This study is Health Canada regulated

NCT ID: NCT03661385 Completed - Clinical trials for Transposition of Great Vessels

Nitric Oxide During Bypass for Arterial Switch Operation

NASO
Start date: July 11, 2018
Phase: Phase 3
Study type: Interventional

This trial will test if adding nitric oxide (NO) gas to the cardiopulmonary bypass (CPB) circuit in infants undergoing an arterial switch operation (ASO) for Transposition of the Great Arteries (TGA) changes the incidence of major postoperative adverse events (AEs). Major postoperative AEs include cardiac arrest, emergency chest opening, use of ECMO (machine that acts as an artificial heart and lung during surgery), and death. Participants will be randomised to receive oxygen plus nitric oxide (intervention arm) or oxygen without nitric oxide (control arm) during CPB.

NCT ID: NCT03469843 Completed - Clinical trials for Congenital Heart Disease

Characterization of the Cardiac Reinnervation of Patients With Transposition of the Great Arteries Long After Repair With the Arterial Switch Operation. Correlation With Electrocardiographic and Exercise Test Parameters

Start date: April 19, 2018
Phase:
Study type: Observational

Cardiac denervation is inherent to the arterial switch (ASO) technique for the repair of transposition of the great arteries (TGA) and the long term reinnervation process has not been studied. We sought to describe the reinnervation status of adult patients long after the ASO, to identify areas of myocardial perfusion/innervation mismatch and to assess the relation of innervation status and exercise capacity.

NCT ID: NCT03078413 Completed - Clinical trials for Transposition of Great Vessels

Late Function After Surgery for Transposition of the Great Arteries

Start date: March 3, 2017
Phase:
Study type: Observational

The investigators proposed to review the exercise tolerance, cardiac function, and quality of life in patients born with transposition of the great arteries that have undergone surgery with either the Mustard or Senning procedure. Participants will complete a questionnaire. The investigators will review the participants' recent cardiac function testing which will assess their current health status. These tests include an echocardiogram, a metabolic exercise stress test, cardiac imaging, and a 24-hour Holter monitor. This collection of testing results will be compared specifically with previously acquired data during the first phases of this study (published in 2001 and 2007).